BBLG Q1 2020 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$340,050

Net Income

-$596,900

EPS (Diluted)

$-11.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$149,878

Free Cash Flow

-$149,878

Stock-Based Comp.

$15,000

Balance Sheet

Total Assets

$6,964

Total Liabilities

$12M

Stockholders' Equity

-$12M

Cash & Equivalents

$2,432

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$340,050	-$1M	+71.4%
Net Income	-$596,900	-$1M	+57.6%